XML 477 R79.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Based Compensation - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended 24 Months Ended
Mar. 24, 2023
Dec. 31, 2022
Oct. 29, 2020
Sep. 30, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2017
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Number of shares issued under the plan (in shares)         0      
Weighted average remaining contractual term (in years)         3 years 3 months 18 days 4 years 8 months 12 days 5 years 7 months 6 days 6 years
Granted (in shares)         7,000 495,700   15,882,711
Dividend yield         0.00% 0.00%    
Aggregate intrinsic value of options outstanding         $ 25,800      
Intrinsic value of options exercisable         25,800      
Intrinsic value         $ 400 $ 1,800 $ 26,300  
Stock option grants (in dollars per share)         $ 7.05 $ 10.25 $ 15.96  
Unvested stock option awards granted amount         $ 22,200      
Stock-based compensation         8,176 $ 19,602 $ 5,622  
Stock-based compensation         (8,176) (19,602) (5,622)  
Share-based payment arrangement, expense         $ 8,176 $ 19,602 $ 5,622  
Stock Options                
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Minimum estimated fair value percentage of exercise priced on the date of grant         100.00%      
Minimum percentage of shareholders         15.00%      
Minimum estimated percentage of fair value of shares         110.00%      
Weighted average remaining contractual term (in years)         10 years      
Dividend yield         0.00%      
Restricted Stock Units (RSUs)                
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Award vesting percentage         25.00%      
Share-based payment award, restricted stock unit awards vested on the grant date (in shares)         331,873 498,497    
PRSUs | First Quarter                
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Award vesting percentage       50.00%        
PRSUs | Second Quarter                
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Award vesting percentage       50.00%        
Share-based payment arrangement, expense         $ 3,400      
Class A Common Stock                
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Stock-based compensation         1,100 $ 4,600    
Value of restricted stock issued         $ 200,000      
Class A Common Stock | Restricted Stock Units (RSUs)                
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Day average closing date preceding grant date         30 days      
Class A Common Stock | PRSUs                
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Number of shares authorized under the plan (in shares)         1,446,943      
Stock-based compensation   $ 10,100     $ 7,300      
Number of awards convertible into each underlying share (in shares)       1        
Value of shares approved and authorized         3,400      
Share-based payment award, restricted stock unit awards vested on the grant date (in shares) 1,278,465              
Stock-based compensation         $ 2,800      
2020 Equity Incentive Plan | Class A Common Stock                
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Number of shares added to the plan (in shares)     24,097,751          
Number of shares authorized under the plan (in shares)     48,000,000          
ESPP | Stock Options                
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Weighted-average period (in years)         3 years 3 months 18 days      
ESPP | Class A Common Stock                
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Number of shares authorized under the plan (in shares)     3,213,034